Search

Author/Creator Lewis, Ian D.

1. Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients. Issue 6 (20th March 2017)

Authors:
Hiwase, Devendra K.; Singhal, Deepak; Strupp, Corinna; Chhetri, Rakchha; Kutyna, Monika M.; Wee, L. Amilia; Harrison, Peter B.; Nath, Shriram V.; Wickham, Nicholas; Hui, Chi‐Hung; Gray, James X.; Bardy, Peter; Ross, David M.; Lewis, Ian D.; Reynolds, John; To, L. Bik; Germing, Ulrich
Journal:
American journal of hematology
Issue:
Volume 92:Issue 6(2017:Jun.)
Page Start:
508
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma. Issue 4 (21st March 2019)

Authors:
Hapgood, Greg; Stone, Janey M.; Zannino, Diana; George, Anup; Marlton, Paula; Prince, Henry Miles; Hui, Chi-Hung; Prosser, Ian; Lewis, Ian D.; Bradstock, Kenneth; Seymour, John F.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 4(2019)
Page Start:
904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study. (November 2016)

Authors:
Swords, Ronan T.; Greenberg, Peter L.; Wei, Andrew H.; Durrant, Simon; Advani, Anjali S.; Hertzberg, Mark S.; Lewis, Ian D.; Rivera, Gabriel; Gratzinger, Dita; Fan, Alice C.; Felsher, Dean W.; Cortes, Jorge E.; Watts, Justin M.; Yarranton, Geoff T.; Walling, Jackie M.; Lancet, Jeffrey E.
Journal:
Leukemia research
Issue:
Volume 50(2016:Nov.)
Page Start:
123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The preferential occurrence of FLT3‐TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core‐binding factor AML patients. (28th November 2012)

Authors:
Kok, Chung H.; Brown, Anna L.; Perugini, Michelle; Iarossi, Diana G.; Lewis, Ian D.; D'Andrea, Richard J.
Journal:
British journal of haematology
Issue:
Volume 160:Number 4(2013:Feb.)
Page Start:
557
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. Issue 5 (May 2015)

Authors:
He, Simon Z.; Busfield, Samantha; Ritchie, David S.; Hertzberg, Mark S.; Durrant, Simon; Lewis, Ian D.; Marlton, Paula; McLachlan, Andrew J.; Kerridge, Ian; Bradstock, Kenneth F.; Kennedy, Glen; Boyd, Andrew W.; Yeadon, Trina M.; Lopez, Angel F.; Ramshaw, Hayley S.; Iland, Harry; Bamford, Simone;...
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 5(2015:May)
Page Start:
1406
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. (21st August 2014)

Authors:
Bradstock, Kenneth F.; Link, Emma; Collins, Marnie; Di Iulio, Juliana; Lewis, Ian D.; Schwarer, Anthony; Enno, Arno; Marlton, Paula; Hahn, Uwe; Szer, Jeff; Cull, Gavin; Seymour, John F.; the Australasian Leukaemia and Lymphoma Group
Journal:
British journal of haematology
Issue:
Volume 167:Number 5(2014:Dec.)
Page Start:
618
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival. (25th March 2013)

Authors:
Diakiw, Sonya M.; Perugini, Michelle; Kok, Chung H.; Engler, Grant A.; Cummings, Nik; To, Luen Bik; Wei, Andrew H.; Lewis, Ian D.; Brown, Anna L.; D'Andrea, Richard J.
Journal:
British journal of haematology
Issue:
Volume 161:Number 6(2013:Jun.)
Page Start:
884
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Interleukin‐3‐mediated regulation of β‐catenin in myeloid transformation and acute myeloid leukemia. Issue 1 (5th March 2014)

Authors:
Sadras, Teresa; Perugini, Michelle; Kok, Chung H.; Iarossi, Diana G.; Heatley, Susan L.; Brumatti, Gabriela; Samuel, Michael S.; To, Luen B.; Lewis, Ian D.; Lopez, Angel F.; Ekert, Paul G.; Ramshaw, Hayley S.; DˈAndrea, Richard J.
Journal:
Journal of leukocyte biology
Issue:
Volume 96:Issue 1(2014)
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Corrigendum to "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729]. (August 2017)

Authors:
Swords, Ronan T.; Greenberg, Peter L.; Wei, Andrew H.; Durrant, Simon; Advani, Anjali S.; Hertzberg, Mark S.; Lewis, Ian D.; Rivera, Gabriel; Gratzinger, Dita; Fan, Alice C.; Felsher, Dean W.; Cortes, Jorge E.; Watts, Justin M.; Yarranton, Geoff T.; Walling, Jackie M.; Lancet, Jeffrey E.
Journal:
Leukemia research
Issue:
Volume 59(2017:Aug.)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗